As of Tuesday, Precision BioSciences Inc.’s (NASDAQ:DTIL) stock closed at $0.58, up from $0.58 the previous day. While Precision BioSciences Inc. has overperformed by 0.28%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DTIL fell by -60.57%, with highs and lows ranging from $2.12 to $0.51, whereas the simple moving average fell by -42.21% in the last 200 days.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
On June 17, 2022, BMO Capital Markets started tracking Precision BioSciences Inc. (NASDAQ: DTIL) recommending Outperform.
Analysis of Precision BioSciences Inc. (DTIL)
Further, the quarter-over-quarter increase in sales is 166.70%, showing a positive trend in the upcoming months.
One of the most important indicators of Precision BioSciences Inc.’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -150.70% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.60, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and DTIL is recording 722.87K average volume. On a monthly basis, the volatility of the stock is set at 9.39%, whereas on a weekly basis, it is put at 7.09%, with a loss of -0.05% over the past seven days. Furthermore, long-term investors anticipate a median target price of $3.20, showing growth from the present price of $0.58, which can serve as yet another indication of whether DTIL is worth investing in or should be passed over.
How Do You Analyze Precision BioSciences Inc. Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.90%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 47.40% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in DTIL shares?
The recent increase in stakes in DTIL appears to be a result of several institutional investors and hedge funds increasing their positions. Great Point Partners LLC’s position in DTIL has increased by 113.08% in the first quarter. The company now owns 8,099,799 shares of the stock, with a value of $4.26 million, following the purchase of 4,298,494 additional shares during the last quarter. During the last quarter, the company picked up 0 additional shares for a total stake of worth $3.53 million, bringing number of shares owned by the company to 6,715,043.
During the first quarter, The Vanguard Group, Inc. added a 366,452 position in DTIL. CHI Advisors LLC sold an additional 80000.0 shares in the last quarter, decreasing its holdings by -2.25%, now holding 3.47 million shares worth $1.83 million. At the end of the first quarter, Acadian Asset Management LLC increased its DTIL holdings by 8.12% and now holds 2.91 million DTIL shares valued at $1.53 million with the added 0.22 million shares during the period. DTIL shares are owned by institutional investors to the tune of 47.40% at present.
